@ya9gong
DeSci Launchpad Moves to a Factory Model @iccm.eth
It looks like Bio Protocol Season 2 is about to begin — and it’s built on a completely different framework from Season 1.
Transition to a Permissionless System
They’ve moved away from the traditional curation model and introduced a factory-style system, creating an environment where biotech projects can join more freely and independently.
The “Ignition Sales” Mechanism
Initially, sales will start with USDC/Asset pairs
Once project performance is validated, they’ll transition to BIO/Asset pairs
Allocations are distributed proportionally based on BioXP points, with 20% unlocked at TGE and the remaining 80% linearly vested over 30 days — effectively reducing sell pressure right after launch.
x402 Protocol Integration @baseapp.base.eth
By integrating Coinbase’s x402, BioAgents on the Base chain can autonomously execute USDC micropayments — combining AI agents with on-chain payments in a seamless way.
This update clearly shows how launchpad architecture in the DeSci ecosystem is evolving.
💭 What do you think is the most important factor for successful biotech project funding?